Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

23,100 total articles

South Korea CPI Climbs to 3.2% in June, Highest Since December 2023

South Korea CPI Climbs to 3.2% in June, Highest Since December 2023

South Korea's consumer price index rose 3.2% year-on-year in June, the strongest pace since December 2023, with a 0.1% monthly increase. Elevated global oil prices and a softer South Korean won were cited as the main contributors to the acceleration in inflation. The data adds weight to the prospect of a policy rate increase at the Bank of Korea's …

Mexican equities close higher as industrial and consumer sectors drive gains

Mexican equities close higher as industrial and consumer sectors drive gains

Mexico's main equity benchmark, the S&P/BMV IPC, advanced 0.42% at Wednesday's close, led by strength in Industrials, Consumer Goods & Services and Consumer Staples. Market breadth favored winners, with 135 stocks rising versus 102 decliners. Notable individual movers included Gentera, Genomma Lab and Bolsa Mexicana De Valores on the upside, while …

Dan Ives Departs Wedbush to Form AI-Focused Merchant Bank

Dan Ives Departs Wedbush to Form AI-Focused Merchant Bank

Dan Ives, a long-standing technology analyst, is leaving his role at Wedbush Securities to found a merchant bank that will integrate research, advisory, capital raising and investing. The new firm will concentrate on opportunities tied to artificial intelligence and other structural economic shifts, with planned activity across technology, energy a…

Federal Judge Halts Colorado’s Novel Price Cap on Amgen’s Enbrel

Federal Judge Halts Colorado’s Novel Price Cap on Amgen’s Enbrel

A federal judge issued a preliminary injunction blocking Colorado’s planned cap on the price of Amgen’s arthritis treatment Enbrel, finding the drugmaker would likely suffer significant and irreparable harm and that capping a patented drug’s price is not an available option for the state. Colorado had set the cap in October, and the measure was to …

S&P Lowers Dish DBS Ratings to D After Chapter 11 Filing

S&P Lowers Dish DBS Ratings to D After Chapter 11 Filing

S&P Global Ratings cut all ratings on Dish DBS Corp. to D after the EchoStar Corp. subsidiary filed for Chapter 11 on June 30, 2026. The move came ahead of a $2 billion secured-note maturity and followed a previously negotiated restructuring support agreement, with the company saying a delayed spectrum sale to AT&T left it unable to meet the schedu…